Utilising Proteomics and Organoid Cultures for Predicting Treatment Response in Colorectal Cancer
Colorectal cancer (CRC) remains one of the most frequently diagnosed tumours worldwide. Despite advances in surgical intervention and therapeutics, development of chemoresistance remains a challenge to treating CRC. Predicting treatment response in CRC has strongly relied on genomics, transcriptomic...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/82673 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Utilising Proteomics and Organoid Cultures for Predicting Treatment Response in Colorectal Cancer
- Retinoids in Treatment of Colorectal Cancer
- Adjuvant Treatment in Colorectal Cancer
- Endoscopic Diagnosis and Treatment for Colorectal Cancer
- Panitumumab for the Treatment of Metastatic Colorectal Cancer
- Treatment of Metastatic Colorectal Cancer: Beyond Progression
- Anti-EGFR Treatment in Patients with Colorectal Cancer